Mehrdad Hefazi Torghabeh
0000-0001-8860-3380
1 paper found
Refreshing results…
Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
Missing publications? Search for publications with a matching author name.